Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Price Down 0.8% – Here’s Why

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) shares were down 0.8% during mid-day trading on Friday. The stock traded as low as $12.11 and last traded at $12.30. 553,484 shares were traded during mid-day trading, a decline of 7% from the average session volume of 597,667 shares. The stock had previously closed at $12.40.

Analyst Ratings Changes

Several brokerages have issued reports on BAYRY. Deutsche Bank Aktiengesellschaft upgraded Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a report on Thursday, July 2nd. Zacks Research raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Performance

The company’s 50-day moving average is $13.53 and its two-hundred day moving average is $12.63. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The company has a market cap of $48.34 billion, a P/E ratio of -24.12, a price-to-earnings-growth ratio of 1.86 and a beta of 0.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.23 by $0.06. The business had revenue of $12.53 billion for the quarter, compared to analyst estimates of $12.31 billion. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. Equities analysts predict that Bayer Aktiengesellschaft will post 1.27 EPS for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.